Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) SHZ
5.28
-0.12(-2.22%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Shanghai Kaibao Pharmaceutical CO.,Ltd
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1325
First IPO Date
January 08, 2010
Key Executives
| Name | Title | Pay | Year Born |
| Jianzhong Liu | Deputy GM & Non-Independent Director | 0 | 1973 |
| Liwang Ren | Board Secretary & Non-Independent Director | 0 | 1970 |
| Yingbin Zhou | GM & Director | 0 | 1978 |
| Ying Jun Zhu | Deputy General Manager | 0 | 1970 |
| You Long Chen | Financial Director | 0 | 1975 |
| Ya Ru Li | Accounting Supervisor | 0 | N/A |
Description
Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern Chinese medicines primarily in China. Its primary products include Tanreqing injection for the treatment of pneumonia, acute and chronic bronchitis, and upper respiratory tract infection; Tanreqing capsules that clears heat and detoxifies and removes phlegm; tiopronin for injection, which improves liver function of various acute and chronic hepatitis; Tiopronin enteric-coated tablets for adjuvant treatment of chronic hepatitis; and Xiongdan dropping pills that clears heat, calms liver, and improves eyesight. The company was founded in 2000 and is based in Shanghai, China.
